Mukaila A Raji1, Yong-Fang Kuo, Jean L Freeman, James S Goodwin. 1. Memory Loss Clinic, Division of Geriatrics, Department of Internal Medicine, Sealy Center on Aging, University of Texas Medical Branch, Galveston, TX 77555-0460, USA. muraji@utmb.edu
Abstract
BACKGROUND: Preexisting dementia affects cancer care. Knowledge of how dementia affects survival after a cancer diagnosis may help guide cancer care decisions. We therefore examined the associations between preexisting diagnoses of dementia and survival from breast, colon, and prostate cancer. METHODS: We conducted a retrospective cohort study of 106,061 patients aged 68 years or older diagnosed as having breast, colon, or prostate cancer, using data from the linked Surveillance, Epidemiology and End Results-Medicare database. We assessed the risks of mortality from cancer and noncancer causes, stratified by presence or absence of preexisting dementia diagnoses. Cox proportional hazards regression was used to adjust for confounding variables. RESULTS: Seven percent of our sample had preexisting dementia diagnoses. Survival after a cancer diagnosis was markedly worse in demented than in nondemented patients. Most of the excess deaths came from noncancer causes; 33.3% of those with a dementia diagnosis died within 6 months of a cancer diagnosis, compared with 8.5% of patients without dementia. Less than 17.0% of the excess mortality in patients with dementia who had breast or colon cancer was explained by a more advanced cancer stage at diagnosis. None of the excess deaths in prostate cancer was explained by stage at diagnosis. For all 3 cancers, the presence of preexisting dementia diagnoses attenuated the relationship between stage at diagnosis and survival. CONCLUSIONS: Preexisting dementia diagnoses were associated with high mortality, mostly from noncancer causes. The effect of cancer stage at diagnosis on mortality was significantly reduced in older patients with precancer diagnoses of dementia.
BACKGROUND: Preexisting dementia affects cancer care. Knowledge of how dementia affects survival after a cancer diagnosis may help guide cancer care decisions. We therefore examined the associations between preexisting diagnoses of dementia and survival from breast, colon, and prostate cancer. METHODS: We conducted a retrospective cohort study of 106,061 patients aged 68 years or older diagnosed as having breast, colon, or prostate cancer, using data from the linked Surveillance, Epidemiology and End Results-Medicare database. We assessed the risks of mortality from cancer and noncancer causes, stratified by presence or absence of preexisting dementia diagnoses. Cox proportional hazards regression was used to adjust for confounding variables. RESULTS: Seven percent of our sample had preexisting dementia diagnoses. Survival after a cancer diagnosis was markedly worse in demented than in nondemented patients. Most of the excess deaths came from noncancer causes; 33.3% of those with a dementia diagnosis died within 6 months of a cancer diagnosis, compared with 8.5% of patients without dementia. Less than 17.0% of the excess mortality in patients with dementia who had breast or colon cancer was explained by a more advanced cancer stage at diagnosis. None of the excess deaths in prostate cancer was explained by stage at diagnosis. For all 3 cancers, the presence of preexisting dementia diagnoses attenuated the relationship between stage at diagnosis and survival. CONCLUSIONS: Preexisting dementia diagnoses were associated with high mortality, mostly from noncancer causes. The effect of cancer stage at diagnosis on mortality was significantly reduced in older patients with precancer diagnoses of dementia.
Authors: Cary P Gross; Gail J McAvay; Harlan M Krumholz; A David Paltiel; Devina Bhasin; Mary E Tinetti Journal: Ann Intern Med Date: 2006-11-07 Impact factor: 25.391
Authors: Jean L Freeman; Carrie N Klabunde; Nicola Schussler; Joan L Warren; Beth A Virnig; Gregory S Cooper Journal: Med Care Date: 2002-08 Impact factor: 2.983
Authors: Joan L Warren; Linda C Harlan; Angela Fahey; Beth A Virnig; Jean L Freeman; Carrie N Klabunde; Gregory S Cooper; Kevin B Knopf Journal: Med Care Date: 2002-08 Impact factor: 2.983
Authors: Arti Hurria; Ilene S Browner; Harvey Jay Cohen; Crystal S Denlinger; Mollie deShazo; Martine Extermann; Apar Kishor P Ganti; Jimmie C Holland; Holly M Holmes; Mohana B Karlekar; Nancy L Keating; June McKoy; Bruno C Medeiros; Ewa Mrozek; Tracey O'Connor; Stephen H Petersdorf; Hope S Rugo; Rebecca A Silliman; William P Tew; Louise C Walter; Alva B Weir; Tanya Wildes Journal: J Natl Compr Canc Netw Date: 2012-02 Impact factor: 11.908
Authors: Jacques Baillargeon; Yong-Fang Kuo; Yu-Li Lin; Mukaila A Raji; Amanpal Singh; James S Goodwin Journal: J Am Geriatr Soc Date: 2011-07-07 Impact factor: 5.562
Authors: Holly M Holmes; Ruili Luo; Joseph T Hanlon; Linda S Elting; Maria Suarez-Almazor; James S Goodwin Journal: J Am Geriatr Soc Date: 2012-06-15 Impact factor: 5.562
Authors: Yasser Alatawi; Richard A Hansen; Chiahung Chou; Jingjing Qian; Vishnu Suppiramaniam; Guanqun Cao Journal: Breast Cancer Date: 2020-09-09 Impact factor: 4.239
Authors: Tammy T Hshieh; Wooram F Jung; Laura J Grande; Jiaying Chen; Richard M Stone; Robert J Soiffer; Jane A Driver; Gregory A Abel Journal: JAMA Oncol Date: 2018-05-01 Impact factor: 31.777
Authors: Luis Carlos Escobar Pinzon; Matthias Claus; Klaus Maria Perrar; Kirsten Isabel Zepf; Stephan Letzel; Martin Weber Journal: Dtsch Arztebl Int Date: 2013-03-22 Impact factor: 5.594